Larvol Delta - Viracta-Therapeutics-Announces-Completion-of-SecondStage-Enrollment-into-the-Peripheral-TCell-Lymphoma-Cohort-of-the-NAVAL1-Trial

Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe

nanatinostat (VRx-3996) - Viracta Therap

https://www.globenewswire.com/news-release/2024/02/29/2837928/0/en/Viracta-Therapeutics-Announces-Completion-of-Second-Stage-Enrollment-into-the-Peripheral-T-Cell-Lymphoma-Cohort-of-the-NAVAL-1-Trial.html

Feb 29, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next